Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Critical Factors for Binaural Hearing in Children with Bilateral Sequential Cochlear Implantation: First Implant Performance and Inter-Implant Interval.

Jang JH, Roh JM, Choo OS, Kim YJ, Kim H, Park HY, Choung YH.

Audiol Neurootol. 2019 Aug 8:1-9. doi: 10.1159/000500700. [Epub ahead of print]

PMID:
31394542
2.

SeqSQC: A Bioconductor Package for Evaluating the Sample Quality of Next-generation Sequencing Data.

Liu Q, Hu Q, Yao S, Kwan ML, Roh JM, Zhao H, Ambrosone CB, Kushi LH, Liu S, Zhu Q.

Genomics Proteomics Bioinformatics. 2019 Apr;17(2):211-218. doi: 10.1016/j.gpb.2018.07.006. Epub 2019 Apr 5.

3.

Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.

Larsen V, Barlow WE, Yang JJ, Zhu Q, Liu S, Kwan ML, Ergas IJ, Roh JM, Hutchins LF, Kadlubar SA, Albain KS, Rae JM, Yeh IT, Ravdin PM, Martino S, Lyss AP, Osborne CK, Hortobagyi GN, Kushi LH, Hayes DF, Ambrosone CB, Yao S.

Clin Breast Cancer. 2019 Aug;19(4):225-235.e2. doi: 10.1016/j.clbc.2019.02.010. Epub 2019 Mar 6.

PMID:
30928413
4.

Early-onset triple-negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations.

Liu Q, Yao S, Zhao H, Hu Q, Kwan ML, Roh JM, Ambrosone CB, Kushi LH, Liu S, Zhu Q.

Cancer Med. 2019 Apr;8(4):1845-1853. doi: 10.1002/cam4.2047. Epub 2019 Mar 12.

5.

The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.

Kwan ML, Kushi LH, Danforth KN, Roh JM, Ergas IJ, Lee VS, Cannavale KL, Harrison TN, Contreras R, Loo RK, Aaronson DS, Quesenberry CP, Tritchler D, Ghai NR, Quinn VP, Ambrosone CB, Zhang Y, Tang L.

Cancer Causes Control. 2019 Feb;30(2):187-193. doi: 10.1007/s10552-019-1130-8. Epub 2019 Jan 17.

PMID:
30656539
6.

Opportunities to Improve Detection and Treatment of Depression Among Patients With Breast Cancer Treated in an Integrated Delivery System.

Check DK, Kwan ML, Chawla N, Dusetzina SB, Valice E, Ergas IJ, Roh JM, Kolevska T, Rosenstein DL, Kushi LH.

J Pain Symptom Manage. 2019 Mar;57(3):587-595. doi: 10.1016/j.jpainsymman.2018.11.024. Epub 2018 Dec 1.

PMID:
30508637
7.

Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use.

Check DK, Aaronson DS, Nielsen ME, Lee VS, Ergas IJ, Roh JM, Kushi LH, Tang L, Kwan ML.

Urology. 2019 Feb;124:107-112. doi: 10.1016/j.urology.2018.10.016. Epub 2018 Oct 23.

PMID:
30359712
8.

Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions.

Check DK, Chawla N, Kwan ML, Pinheiro L, Roh JM, Ergas IJ, Stewart AL, Kolevska T, Ambrosone C, Kushi LH.

Breast Cancer Res Treat. 2018 Aug;170(3):593-603. doi: 10.1007/s10549-018-4776-0. Epub 2018 Apr 5.

9.

Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy.

Kwan ML, Yao S, Laurent CA, Roh JM, Quesenberry CP Jr, Kushi LH, Lo JC.

Breast Cancer Res Treat. 2018 Apr;168(2):523-530. doi: 10.1007/s10549-017-4626-5. Epub 2017 Dec 16.

10.

Breast Cancer Chemoprevention in an Integrated Health Care Setting.

Nichols HB, Stürmer T, Lee VS, Anderson C, Lee JS, Roh JM, Visvanathan K, Muss H, Kushi LH.

JCO Clin Cancer Inform. 2017 Nov;1:1-12. doi: 10.1200/CCI.16.00059.

11.

Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study.

Engmann NJ, Ergas IJ, Yao S, Kwan ML, Roh JM, Ambrosone CB, Kushi LH, Fejerman L.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1466-1469. doi: 10.1158/1055-9965.EPI-17-0148.

12.

Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer.

Kwan ML, Roh JM, Laurent CA, Lee J, Tang L, Hershman D, Kushi LH, Yao S.

Cancer Causes Control. 2017 Jun;28(6):557-562. doi: 10.1007/s10552-017-0888-9. Epub 2017 Mar 27.

13.

Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study.

Shariff-Marco S, Von Behren J, Reynolds P, Keegan TH, Hertz A, Kwan ML, Roh JM, Thomsen C, Kroenke CH, Ambrosone C, Kushi LH, Gomez SL.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):505-515. doi: 10.1158/1055-9965.EPI-16-0932. Epub 2017 Feb 2.

14.

Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.

Yao S, Zhang Y, Tang L, Roh JM, Laurent CA, Hong CC, Hahn T, Lo JC, Ambrosone CB, Kushi LH, Kwan ML.

Breast Cancer Res Treat. 2017 Feb;161(3):501-513. doi: 10.1007/s10549-016-4068-5. Epub 2016 Dec 3.

15.

Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.

Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, Hong CC, McCann SE, Tang L, Davis W, Liu S, Quesenberry CP Jr, Lee MM, Ambrosone CB, Kushi LH.

JAMA Oncol. 2017 Mar 1;3(3):351-357. doi: 10.1001/jamaoncol.2016.4188.

16.

BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.

Greenlee H, Hershman DL, Shi Z, Kwan ML, Ergas IJ, Roh JM, Kushi LH.

J Natl Cancer Inst. 2016 Oct 28;109(2). pii: djw206. Print 2017 Feb.

17.

Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study.

Kwan ML, Yao S, Lee VS, Roh JM, Zhu Q, Ergas IJ, Liu Q, Zhang Y, Kutner SE, Quesenberry CP Jr, Ambrosone CB, Kushi LH.

Breast Cancer Res Treat. 2016 Aug;159(1):119-29. doi: 10.1007/s10549-016-3913-x. Epub 2016 Jul 22.

18.

Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.

Greenlee H, Neugut AI, Falci L, Hillyer GC, Buono D, Mandelblatt JS, Roh JM, Ergas IJ, Kwan ML, Lee M, Tsai WY, Shi Z, Lamerato L, Kushi LH, Hershman DL.

JAMA Oncol. 2016 Sep 1;2(9):1170-6. doi: 10.1001/jamaoncol.2016.0685.

19.

Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC).

Vigen C, Kwan ML, John EM, Gomez SL, Keegan TH, Lu Y, Shariff-Marco S, Monroe KR, Kurian AW, Cheng I, Caan BJ, Lee VS, Roh JM, Bernstein L, Sposto R, Wu AH.

Cancer Causes Control. 2016 Mar;27(3):391-401. doi: 10.1007/s10552-016-0715-8. Epub 2016 Jan 21.

20.

The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiology.

Zhu Q, Hu Q, Shepherd L, Wang J, Wei L, Morrison CD, Conroy JM, Glenn ST, Davis W, Kwan ML, Ergas IJ, Roh JM, Kushi LH, Ambrosone CB, Liu S, Yao S.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1207-13. doi: 10.1158/1055-9965.EPI-15-0205. Epub 2015 May 19.

21.

History of Recreational Physical Activity and Survival After Breast Cancer: The California Breast Cancer Survivorship Consortium.

Lu Y, John EM, Sullivan-Halley J, Vigen C, Gomez SL, Kwan ML, Caan BJ, Lee VS, Roh JM, Shariff-Marco S, Keegan TH, Kurian AW, Monroe KR, Cheng I, Sposto R, Wu AH, Bernstein L.

Am J Epidemiol. 2015 Jun 15;181(12):944-55. doi: 10.1093/aje/kwu466. Epub 2015 Apr 29.

22.

Bone health history in breast cancer patients on aromatase inhibitors.

Kwan ML, Lo JC, Tang L, Laurent CA, Roh JM, Chandra M, Hahn TE, Hong CC, Sucheston-Campbell L, Hershman DL, Quesenberry CP Jr, Ambrosone CB, Kushi LH, Yao S.

PLoS One. 2014 Oct 29;9(10):e111477. doi: 10.1371/journal.pone.0111477. eCollection 2014.

23.

Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data.

Mandelblatt JS, Huang K, Makgoeng SB, Luta G, Song JX, Tallarico M, Roh JM, Munneke JR, Houlston CA, McGuckin ME, Cai L, Clarke Hillyer G, Hershman DL, Neugut AI, Isaacs C, Kushi L.

J Oncol Pract. 2015 Jan;11(1):e1-8. doi: 10.1200/JOP.2013.001288. Epub 2014 Aug 26.

24.

Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study.

Greenlee H, Kwan ML, Ergas IJ, Strizich G, Roh JM, Wilson AT, Lee M, Sherman KJ, Ambrosone CB, Hershman DL, Neugut AI, Kushi LH.

BMC Cancer. 2014 May 29;14:382. doi: 10.1186/1471-2407-14-382.

25.

Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer Survivorship Consortium.

Kwan ML, John EM, Caan BJ, Lee VS, Bernstein L, Cheng I, Gomez SL, Henderson BE, Keegan TH, Kurian AW, Lu Y, Monroe KR, Roh JM, Shariff-Marco S, Sposto R, Vigen C, Wu AH.

Am J Epidemiol. 2014 Jan 1;179(1):95-111. doi: 10.1093/aje/kwt233. Epub 2013 Oct 9.

26.

The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival.

Wu AH, Gomez SL, Vigen C, Kwan ML, Keegan TH, Lu Y, Shariff-Marco S, Monroe KR, Kurian AW, Cheng I, Caan BJ, Lee VS, Roh JM, Sullivan-Halley J, Henderson BE, Bernstein L, John EM, Sposto R.

Cancer Causes Control. 2013 Oct;24(10):1821-36. doi: 10.1007/s10552-013-0260-7. Epub 2013 Jul 18.

27.

Patient-physician interaction and quality of life in recently diagnosed breast cancer patients.

Kwan ML, Tam EK, Ergas IJ, Rehkopf DH, Roh JM, Lee MM, Somkin CP, Stewart AL, Kushi LH.

Breast Cancer Res Treat. 2013 Jun;139(2):581-95. doi: 10.1007/s10549-013-2569-z. Epub 2013 May 29.

28.

Employment status and quality of life in recently diagnosed breast cancer survivors.

Timperi AW, Ergas IJ, Rehkopf DH, Roh JM, Kwan ML, Kushi LH.

Psychooncology. 2013 Jun;22(6):1411-20. doi: 10.1002/pon.3157. Epub 2012 Aug 22.

29.

Change in physical activity during active treatment in a prospective study of breast cancer survivors.

Kwan ML, Sternfeld B, Ergas IJ, Timperi AW, Roh JM, Hong CC, Quesenberry CP, Kushi LH.

Breast Cancer Res Treat. 2012 Jan;131(2):679-90. doi: 10.1007/s10549-011-1788-4. Epub 2011 Sep 28.

30.

Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsy.

Lauritzen F, Perez EL, Melillo ER, Roh JM, Zaveri HP, Lee TS, Wang Y, Bergersen LH, Eid T.

Neurobiol Dis. 2012 Jan;45(1):165-76. doi: 10.1016/j.nbd.2011.08.001. Epub 2011 Aug 10.

31.

Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study.

Mandelblatt JS, Luta G, Kwan ML, Makgoeng SB, Ergas IJ, Roh JM, Sternfeld B, Adams-Campbell LL, Kushi LH.

Breast Cancer Res Treat. 2011 Sep;129(2):521-9. doi: 10.1007/s10549-011-1483-5. Epub 2011 Apr 8.

32.

Adiponectin is independently associated with apolipoprotein B to A-1 ratio in Koreans.

Park JS, Cho MH, Nam JS, Yoo JS, Lee YB, Roh JM, Ahn CW, Jee SH, Cha BS, Lee EJ, Lim SK, Kim KR, Lee HC.

Metabolism. 2010 May;59(5):677-82. doi: 10.1016/j.metabol.2009.09.013. Epub 2009 Nov 14.

PMID:
19914667
33.

Survey of selected hospital pharmacy services.

Upton JH, Crouch JB, Roh JM.

Hosp Pharm. 1978 Mar;13(3):152-3, 156-7. No abstract available.

PMID:
10306927

Supplemental Content

Support Center